Beside the already described down-regulation of MHC-I expression in tumor cells in vivo hampering CD8+ CTL recognition, it is now well established that insufficient response was due to the lack of efficient help provided to CTL by CD4+ Th cells [24,25]. The gene discussed is CD8A; the disease is neoplasm.